Homocysteine exerts genotoxic and antioxidative effects in vitro

Toxicology in Vitro

Volumn 21, Issue 8, 2007, Pages 1402-1408

  Fink, K ^a   Brink, A ^a   Vienken, J ^b   Heidland, A ^a   Stopper, H ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b FRESENIUS MEDICAL CARE   (Germany)

Author keywords

Genomic damage; Glutathione; Homocysteine; Oxidative stress; Renal disease

Indexed keywords

ANTIOXIDANT; DNA; HOMOCYSTEINE; HYDROGEN PEROXIDE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER INCIDENCE; CARDIOVASCULAR RISK; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROTECTION; COMET ASSAY; DIAGNOSTIC VALUE; DNA METHYLATION; GENETIC DAMAGE; GENOTOXICITY; GLUTATHIONE METABOLISM; IN VITRO STUDY; KIDNEY FAILURE; MICRONUCLEUS TEST; NONHUMAN; UREMIA;

ANIMALS; ANTIOXIDANTS; CELL CYCLE; CELL LINE, TUMOR; CYTOSINE; DNA METHYLATION; HOMOCYSTEINE; MICE; MUTAGENS; OXIDATIVE STRESS;

EID: 36048969475     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2007.05.005     Document Type: Article

References (33)

1. Au-Yeung K.K., Woo C.W., et al. Hyperhomocysteinemia activates nuclear factor-kappaB in endothelial cells via oxidative stress. Circulation Research 94 1 (2004) 28-36
2. Bonaa K.H., Njolstad I., et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. New England Journal of Medicine 354 15 (2006) 1578-1588
3. Chen R.Z., Pettersson U., et al. DNA-hypomethylation leads to elevated mutation rates. Nature 395 6697 (1998) 89-93
4. Crott J., Thomas P., et al. Normal human lymphocytes exhibit a wide range of methionine-dependency which is related to altered cell division but not micronucleus frequency. Mutagenesis 16 4 (2001) 317-322
5. Dong F., Zhang X., et al. Possible involvement of NADPH oxidase and JNK in homocysteine-induced oxidative stress and apoptosis in human umbilical vein endothelial cells. Cardiovascular Toxicology 5 1 (2005) 9-20
6. Fenech M. Micronucleus frequency in human lymphocytes is related to plasma vitamin B12 and homocysteine. Mutation Research 428 1-2 (1999) 299-304
7. Fenech M. The in vitro micronucleus technique. Mutation Research 455 1-2 (2000) 81-95
8. Hoffman D.R., Marion D.W., et al. S-Adenosylmethionine and S-adenosylhomocystein metabolism in isolated rat liver. Effects of l-methionine, l-homocystein, and adenosine. Journal of Biological Chemistry 255 22 (1980) 10822-10827
9. Ingrosso D., Cimmino A., et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with Uraemia. Lancet 361 9370 (2003) 1693-1699
10. James S.J., Melnyk S., et al. Elevation in S-adenosylhomocysteine and DNA-hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. Journal of Nutrition 132 8 Suppl (2002) 2361S-2366S
11. Kirkland D.J., Henderson L., et al. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European scientific committee for cosmetics and non-food products for the evaluation of hair dyes. Mutation Research 588 2 (2005) 88-105
12. Lonn E., Yusuf S., et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. New England Journal of Medicine 354 15 (2006) 1567-1577
13. Lynch S.M., Campione A.L., et al. Plasma thiols inhibit hemin-dependent oxidation of human low-density lipoprotein. Biochimica and Biophysica Acta 1485 1 (2000) 11-22
14. Maisonneuve P., Agodoa L., et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 354 9173 (1999) 93-99
15. Mallamaci F., Zoccali C., et al. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney International 61 2 (2002) 609-614
16. Menon V., Sarnak M.J., et al. Relationship between homocysteine and mortality in chronic kidney disease. Circulation 113 12 (2006) 1572-1577
17. Miller B., Potter-Locher F., et al. Evaluation of the in vitro micronucleus test as an alternative to the in vitro chromosomal aberration assay: position of the GUM Working Group on the in vitro micronucleus test, Gesellschaft fuer Umwelt-Mutations-forschung. Mutation Research 410 1 (1998) 81-116
18. Nair A.P., Nemirovsky D., et al. Elevated homocysteine levels in patients with end-stage renal disease. Mount Sinai Journal of Medicine 72 6 (2005) 365-373
19. Nakanishi T., Akabane E.R., et al. Comparison of cytotoxicity of cysteine and homocysteine for renal epithelial cells. Nephron Experimental Nephrology 100 1 (2005) e11-e20
20. Outinen P.A., Sood S.K., et al. Characterization of the stress-inducing effects of homocysteine. Biochemical Journal 332 Pt 1 (1998) 213-221
21. Perez-de-Arce K., Foncea R., et al. Reactive oxygen species mediates homocysteine-induced mitochondrial biogenesis in human endothelial cells: modulation by antioxidants. Biochemical and Biophysical Research Communication 338 2 (2005) 1103-1109
22. Perna A.F., Ingrosso D., et al. Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia. Kidney International 47 1 (1995) 247-253
23. Perna A.F., Ingrosso D., et al. Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients-Italian initiative on uremic hyperhomocysteinemia (IIUH). Journal of Nephrology 16 4 (2003) 516-521
24. Perna A.F., Satta E., et al. Increased plasma protein homocysteinylation in hemodialysis patients. Kidney International 69 5 (2006) 869-876
25. Sethi A.S., Lees D.M., et al. Homocysteine-induced endothelin-1 release is dependent on hyperglycaemia and reactive oxygen species production in bovine aortic endothelial cells. Journal of Vascular Research 43 2 (2006) 175-183
26. Singh N., McCoy M., et al. A simple technique for quantitation of low levels of DNA damage in individual cells. Experimental Cell Research 175 1 (1988) 184-191
27. Stopper H., Boullay F., et al. Comet-assay analysis identifies genomic damage in lymphocytes of uremic patients. American Journal of Kidney Disease. 38 2 (2001) 296-301
28. Stopper H., Meysen T., et al. Increased genomic damage in lymphocytes of patients before and after long-term maintenance hemodialysis therapy. American Journal of Kidney Disease 34 3 (1999) 433-437
29. Teschner M., Garte C., et al. Incidence and spectrum of malignant disease among dialysis patients in North Bavaria. Deutsche Medizinische Wochenschrift 127 47 (2002) 2497-2502
30. Tyagi N., Ovechkin A.V., Lominadze D., Moshal K.S., and Tyagi S.C. Mitochondrial mechanism of microvascular endothelial cells apoptosis in hyperhomocysteinemia. Journal of Cellular Biochemistry 98 5 (2006) 1150-1162
31. Vollset S.E., Refsum H., et al. Plasma total homocysteine and cardiovascular and non-cardiovascular mortality: the Hordaland Homocysteine Study. American Journal of Clinical Nutrition 74 1 (2001) 130-136
32. Wu L.L., and Wu J.T. Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker. Clinica Chimica Acta 322 1-2 (2002) 21-28
33. Zaina S., Lindholm M.W., et al. Nutrition and aberrant DNA-methylation patterns in atherosclerosis: more than just hyperhomocysteinemia?. Journal of Nutrition 135 1 (2005) 5-8